ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025
Impact of Alcohol Consumption on Selected Cancer Incidence Trends among Adults in the United States, 2008 to 2019.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alcohol use disorder: an Australian perspective on screening, diagnosis, treatment and prevention.Internal medicine journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAlcohol consumption is a risk factor for certain cancers and is increasing in the United States. We estimated the impact of alcohol consumption on cancer incidence trends in the United States from 2008 to 2019 across six alcohol-related cancers among men and women.
methodsAverage daily alcohol consumption (ADC) was calculated from the National Health Interview Survey (1998-2009) and adjusted to per capita sales data to account for underreporting alcohol use. Population-attributable fractions (PAF) were calculated combining RRs from large meta-analyses and annual ADC estimates for six cancers: female breast cancer, colorectal cancer, esophageal squamous cell carcinoma, laryngeal cancer, liver cancer, and oral and pharyngeal cancer assuming a 10-year latency period. PAF estimates were combined with cancer registry data to calculate incidence rates attributable (and unattributable) to ADCs.
resultsThe highest PAFs were observed for esophageal squamous cell carcinoma, ranging from 13.9% to 16.7% in women and 26.6% to 28.7% in men. The largest increase in overall alcohol-attributable cancer rates was for breast cancer among women, increasing from 6.6 to 8.1 cases per 100,000. High ADC contributed to the most cancer cases; however, even low ADC levels translated to increased cancer risk. An estimated 18,463 of 297,790 new US breast cancer cases will be attributable to alcohol, with 4,958 due to low consumption.
conclusionsThe PAFs for alcohol-related cancers have increased among women and men. IMPACT: Alcohol consumption is an important contributor to cancer incidence, and troublingly its impact has increased over time. Implementing strategies to reduce alcohol use at the population level could help lower the incidence of alcohol-associated cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.